Stabilization of p22phox by hypoxia promotes pulmonary hypertension

Aims: Hypoxia and reactive oxygen species (ROS) have been shown to play a role in the pathogenesis of pulmonary hypertension (PH), a potentially fatal disorder characterized by pulmonary vascular remodeling, elevated pulmonary arterial pressure, and right ventricular hypertrophy. However, how they a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zhang, Zuwen (VerfasserIn) , Weitnauer, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2019
In: Antioxidants & redox signaling
Year: 2018, Jahrgang: 30, Heft: 1, Pages: 56-73
ISSN:1557-7716
DOI:10.1089/ars.2017.7482
Online-Zugang:Verlag, Volltext: https://doi.org/10.1089/ars.2017.7482
Verlag, Volltext: https://www.liebertpub.com/doi/10.1089/ars.2017.7482
Volltext
Verfasserangaben:Zuwen Zhang, Benjamin Trautz, Damir Kračun, Frederick Vogel, Michael Weitnauer, Katharina Hochkogler, Andreas Petry and Agnes Görlach

MARC

LEADER 00000caa a22000002c 4500
001 1670453170
003 DE-627
005 20220816202038.0
007 cr uuu---uuuuu
008 190801r20192018xx |||||o 00| ||eng c
024 7 |a 10.1089/ars.2017.7482  |2 doi 
035 |a (DE-627)1670453170 
035 |a (DE-599)KXP1670453170 
035 |a (OCoLC)1341235252 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 29  |2 sdnb 
100 1 |a Zhang, Zuwen  |e VerfasserIn  |0 (DE-588)1192044835  |0 (DE-627)1670511480  |4 aut 
245 1 0 |a Stabilization of p22phox by hypoxia promotes pulmonary hypertension  |c Zuwen Zhang, Benjamin Trautz, Damir Kračun, Frederick Vogel, Michael Weitnauer, Katharina Hochkogler, Andreas Petry and Agnes Görlach 
264 1 |c 2019 
300 |a 18 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online: 20 Nov 2018 
500 |a Gesehen am 01.08.2019 
520 |a Aims: Hypoxia and reactive oxygen species (ROS) have been shown to play a role in the pathogenesis of pulmonary hypertension (PH), a potentially fatal disorder characterized by pulmonary vascular remodeling, elevated pulmonary arterial pressure, and right ventricular hypertrophy. However, how they are linked in the context of PH is not completely understood. We, therefore, investigated the role of the NADPH oxidase subunit p22phox in the response to hypoxia both in vitro and in vivo.Results: We found that hypoxia decreased ubiquitinylation and proteasomal degradation of p22phox dependent on prolyl hydroxylases (PHDs) and the E3 ubiquitin ligase protein von Hippel Lindau (pVHL), which resulted in p22phox stabilization and accumulation. p22phox promoted vascular proliferation, migration, and angiogenesis under normoxia and hypoxia. Increased levels of p22phox were also detected in lungs and hearts from mice with hypoxia-induced PH. Mice harboring a point mutation (Y121H) in the p22phox gene, which resulted in decreased p22phox stability and subsequent loss of this protein, were protected against hypoxia-induced PH. Mechanistically, p22phox contributed to ROS generation under normoxia, hypoxia, and hypoxia/reoxygenation. p22phox increased the levels and activity of HIF1α, the major cellular regulator of hypoxia adaptation, under normoxia and hypoxia, possibly by decreasing the levels of the PHD cofactors ascorbate and iron(II), and it contributed to the downregulation of the tumor suppressor miR-140 by hypoxia.Innovation: These data identify p22phox as an important regulator of the hypoxia response both in vitro and in vivo.Conclusion: p22phox-dependent NADPH oxidases contribute to the pathophysiology of PH induced by hypoxia. 
534 |c 2018 
700 1 |a Weitnauer, Michael  |d 1978-  |e VerfasserIn  |0 (DE-588)1022105469  |0 (DE-627)715866931  |0 (DE-576)364827424  |4 aut 
773 0 8 |i Enthalten in  |t Antioxidants & redox signaling  |d Larchmont, NY : Liebert, 1999  |g 30(2019), 1, Seite 56-73  |h Online-Ressource  |w (DE-627)325789428  |w (DE-600)2039747-1  |w (DE-576)254079474  |x 1557-7716  |7 nnas  |a Stabilization of p22phox by hypoxia promotes pulmonary hypertension 
773 1 8 |g volume:30  |g year:2019  |g number:1  |g pages:56-73  |g extent:18  |a Stabilization of p22phox by hypoxia promotes pulmonary hypertension 
856 4 0 |u https://doi.org/10.1089/ars.2017.7482  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.liebertpub.com/doi/10.1089/ars.2017.7482  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190801 
993 |a Article 
994 |a 2019 
998 |g 1022105469  |a Weitnauer, Michael  |m 1022105469:Weitnauer, Michael  |d 910000  |d 911700  |e 910000PW1022105469  |e 911700PW1022105469  |k 0/910000/  |k 1/910000/911700/  |p 5 
999 |a KXP-PPN1670453170  |e 3502501890 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Zhang, Zuwen","roleDisplay":"VerfasserIn","role":"aut","family":"Zhang","given":"Zuwen"},{"given":"Michael","family":"Weitnauer","role":"aut","display":"Weitnauer, Michael","roleDisplay":"VerfasserIn"}],"title":[{"title":"Stabilization of p22phox by hypoxia promotes pulmonary hypertension","title_sort":"Stabilization of p22phox by hypoxia promotes pulmonary hypertension"}],"recId":"1670453170","language":["eng"],"note":["Published online: 20 Nov 2018","Gesehen am 01.08.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Zuwen Zhang, Benjamin Trautz, Damir Kračun, Frederick Vogel, Michael Weitnauer, Katharina Hochkogler, Andreas Petry and Agnes Görlach"]},"id":{"eki":["1670453170"],"doi":["10.1089/ars.2017.7482"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"2019"}],"relHost":[{"title":[{"subtitle":"ARS","title":"Antioxidants & redox signaling","title_sort":"Antioxidants & redox signaling"}],"pubHistory":["1.1999 -"],"titleAlt":[{"title":"Antioxidants and redox signaling"},{"title":"ARS"},{"title":"ARS discoveries"},{"title":"ARS therapeutics"}],"part":{"extent":"18","volume":"30","text":"30(2019), 1, Seite 56-73","issue":"1","pages":"56-73","year":"2019"},"disp":"Stabilization of p22phox by hypoxia promotes pulmonary hypertensionAntioxidants & redox signaling","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 30.10.2018","Inhaltl. Gliederung ab 2013 monatl.: Therapeutics; zweimonatl.: Discoveries"],"language":["eng"],"recId":"325789428","origin":[{"dateIssuedDisp":"1999-","publisher":"Liebert","dateIssuedKey":"1999","publisherPlace":"Larchmont, NY"}],"id":{"issn":["1557-7716"],"zdb":["2039747-1"],"eki":["325789428"]},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"18 S."}]} 
SRT |a ZHANGZUWENSTABILIZAT2019